Summary
The product TREN E-200 (Trenbolone Enanthate 200 mg), manufactured by Intex Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number O-2219, was submitted by Intex Pharma and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of Trenbolone Enanthate at 211.05 mg/ml, which is 5.53% above the labeled claim of 200 mg/ml.
The testing process began on 8 October 2024, with the sample received on 22 October 2024, and analysis completed on 25 October 2024. While the results confirm a slight overdosage, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Intex Pharma
- Product Name: TREN E-200 (Trenbolone Enanthate 200 mg)
- Active Ingredient: Trenbolone Enanthate
- Batch Number: O-2219
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51212
- Testing Ordered: 8 October 2024
- Sample Received: 22 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Intex Pharma (Manufacturer)
- Analysis Paid For By: Intex Pharma (Manufacturer)
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 211.05 mg/ml
- Accuracy: 105.53% (5.53% above the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51212_ZV9NPHXTEKJJ
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the presence of Trenbolone Enanthate at a concentration slightly above the labeled claim. While this may not pose an immediate concern, consistency in manufacturing is crucial for consumer trust. Since Intex Pharma submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that TREN E-200 contains Trenbolone Enanthate at 211.05 mg/ml, exceeding the stated 200 mg/ml specification by 5.53%. While this batch exhibits strong quality control, continued testing is essential to ensure consistent dosing. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
